2228. Late Viral Relapse After Direct-Acting Antiviral Treatment in Hepatitis C Virus-Infected Cancer Patients

por Angelidakis, Georgios, Nowbakht, Cima, Torres, Harrys
Publicado 2018

2226. Immune Checkpoint Inhibitors in Solid Tumor Patients with Chronic Hepatitis C Virus Infection: A Prospective Case-Series

por Hosry, Jeff, Naing, Aung, Torres, Harrys
Publicado 2018

2197. Hepatitis B Reactivation in Patients with Malignancies Undergoing Treatment for Hepatitis C Infection with Direct-Acting Antivirals

por Pritchard, Haley, Hwang, Jessica P, Torres, Harrys
Publicado 2018

Direct-acting Antivirals Induce Lymphoproliferative Disease Response in HCV-infected Patients: A Prospective Case Series

por Hosry, Jeff, Economides, Minas, Samaniego, Felipe, Torres, Harrys
Publicado 2017

2227. Short-Duration of Direct-Acting Antivirals in Hepatitis C Virus-Infected Cancer Patients

por Hosry, Jeff, Angelidakis, Georgios, Granwehr, Bruno, Torres, Harrys
Publicado 2018

Management of Multiple Myeloma Complicated by Hepatitis C Virus Reactivation: The Role of New Antiviral Therapy

por Mahale, Parag, Thomas, Sheeba K., Kyvernitakis, Andreas, Torres, Harrys A.
Publicado 2015

The use of Direct-Acting Antivirals in Hepatitis C Virus-Infected Patients with Hepatocellular Carcinoma

por Economides, Minas, Hosry, Jeff, Angelidakis, Georgios, Kaseb, Ahmed, Torres, Harrys
Publicado 2017

919. Rates of False-Positive Hepatitis B Surface Antigen Is Low in Cancer Patients

por Klingen, Joseph, Yibirin, Marcel, Hwang, Jessica P, Torres, Harrys A
Publicado 2021

Telaprevir-containing regimen for treatment of hepatitis C virus infection in patients with hepatocellular carcinoma awaiting liver transplantation: a case series

por Torres, Harrys A, Kaseb, Ahmed, Mahale, Parag, Miller, Ethan, Frenette, Catherine
Publicado 2014

Salvage Therapy in Cancer Patients With Hepatitis C Infection Failing Direct-Acting Antivirals: A Prospective Study

por Pritchard, Haley, Jandhyala, Deeksha, Economides, Minas Platon, Hosry, Jeff, Torres, Harrys
Publicado 2017

Hepatitis C virus-associated hepatocellular carcinoma as a second primary malignancy: exposing an overlooked presentation of liver cancer

por Dandachi, Dima, Hassan, Manal, Kaseb, Ahmed, Angelidakis, Georgios, Torres, Harrys A
Publicado 2018

Salvage therapy in cancer patients with hepatitis C without sustained virologic response after direct‐acting antivirals—A prospective study

por Pritchard, Haley, Jandhyala, Deeksha, Hosry, Jeff, Angelidakis, Georgios, Torres, Harrys A
Publicado 2019

Challenge of hepatitis C in Egypt and hepatitis B in Mauritania

por Raad, Issam I, Chaftari, Anne-Marie, Torres, Harrys A, Ayoub, Ehab Mouris, Narouz, Liliane Iskander, Bartek, Jalen, Hachem, Ray
Publicado 2018

Invasive Mold Infections (IMIs) of the Central Nervous System (CNS) in Patients with Hematologic Cancer (HC) (2000–2016): Uncommon but Deadly

por Economides, Minas Platon, Ballester, Leomar, Kumar, VInc.e, Jiang, Ying, Tarrand, Jeffrey J, Prieto, Victor, Torres, Harrys, Kontoyiannis, Dimitrios P
Publicado 2017

288. Hepatitis B Virus Reactivation in Patients with Hematologic Malignancies after Anticancer Therapy Which Included Ibrutinib

por Malek, Alexandre, Nieto, Yago, Szvalb, Ariel D, Siddiqui, Shaheer, Shafi, Mehnaz A, Hwang, Jessica P, Raad, Issam I, Torres, Harrys A
Publicado 2019

Serologic versus molecular testing for screening for hepatitis C virus infection in patients with hematologic malignancies

por Torres, Harrys A., Angelidakis, Georgios, Jiang, Ying, Economides, Minas, Mustafayev, Khalis, Yibirin, Marcel, Orlowski, Robert, Champlin, Richard, Verstovsek, Srdan, Raad, Issam
Publicado 2022

1052. Serologic vs. molecular testing for screening for hepatitis C virus infection in patients with hematologic malignancies with and without prior hematopoietic cell transplant r...

por Torres, Harrys A, Angelidakis, Georgios, Jiang, Ying, Economides, Minas, Yibirin, Marcel, MD, Robert Orlowski, Champlin, Richard, Verstovsek, Srdan, Raad, Issam I, Raad, Issam I
Publicado 2020

1410. Isoniazid Therapy for Latent Tuberculosis Infection in Patients with Cancer Treated with Checkpoint Inhibitors Immunotherapy

por Malek, Alexandre, Chaftari, Patrick, Okhuysen, Pablo C, Dagher, Hiba, Torres, Harrys A, Hachem, Ray Y, Chaftari, Anne-Marie, Viola, George, Kontoyiannis, Dimitrios P, Mulanovich, Victor E, Raad, Issam I
Publicado 2021

Safety and Efficacy of Immune Checkpoint Inhibitors in Patients with Cancer and Viral Hepatitis: The MD Anderson Cancer Center Experience

por Nardo, Mirella, Yilmaz, Bulent, Nelson, Blessie Elizabeth, Torres, Harrys A, Wang, Lan Sun, Granwehr, Bruno Palma, Song, Juhee, Dalla Pria, Hanna R F, Trinh, Van A, Glitza Oliva, Isabella C, Patel, Sapna P, Tannir, Nizar M, Kaseb, Ahmed Omar, Altan, Mehmet, Lee, Sunyoung S, Miller, Ethan, Zhang, Hao, Stephen, Bettzy A, Naing, Aung
Publicado 2023

22. International Multicenter Study Comparing Cancer to Non-Cancer Patients with COVID-19: Impact of Risk Factors and Treatment Modalities on Outcome

por Hachem, Ray Y, Chaftari, Anne-Marie, Masayuki, Nigo, Hamerschlak, Nelson, Dagher, Hiba, Jiang, Ying, Siddiqui, Bilal, Bayle, Arnaud, Somer, Robert, Cruz, Ana Fernandez, Gorak, Edward, Bhinder, Arvinder, Mori, Nobuyoshi, Datoguia, Tarcila, Shelanski, Samuel, Dragvich, Tomislav, Kiat, Yee Elise Vong, Fakhreddine, Suha, Hanna, Pierre Abi, Chemaly, Roy F, Mulanovich, Victor E, Adachi, Javier, Borjan, Jovan, Khawaja, Fareed, Granwehr, Bruno, John, Teny, Guevara, Eduardo Yepez, Torres, Harrys A, Slavin, Monica, Teh, Benjamin, Subbiah, Vivek, Kontoyiannis, Dimitrios P, Malek, Alexandre, Raad, Issam I
Publicado 2021